Key Takeaways:

  • Our experts help clients address PFAS-related regulatory and exposure risks to guide workplace strategies aligned with OSHA Hazard Communication requirements (29 CFR 1910.1200).
  • RHP Risk Management conducts health and safety audits and safety data sheet (SDS) reviews to evaluate potential PFAS hazards and ensure compliance with OSHA’s standards for chemical safety in the workplace.
  • RHP performs human health risk assessments and tailors risk communications for the development of control measures and training programs that reduce PFAS exposure in the workplace, supporting OSHA’s emphasis on hazard prevention and worker education.

PFAS are a complex group of synthetic chemicals consisting of carbon-fluorine bonds which are used across industries and in primary and secondary consumer products due to their thermal and chemical stability and water and stain resistance.

With the regulatory liabilities, exposure-related challenges, toxicology complexities, and expansive epidemiological literature surrounding PFAS, both nationally and internationally, RHP Risk Management experts can provide assistance and guidance with this family of chemicals through:

  • Regulatory Assistance
    • Compliance for use and waste
    • Interpretation of proposed rules and submission of comments
  • Health and Safety Audits for manufacturers or users
    • Safety Data Sheet evaluation
    • Historic waste processes and secondary use
  • Product Support
    • Labeling throughout product lifestyle from origin to use and distribution
    • Formula reviews of products
  • Human Health Risk Assessment
    • Development of Hazard Summaries
    • Exposure Modeling and Monitoring
    • Risk Evaluation
    • Consult on appropriate use of toxicological data, including pharmacokinetic considerations
    • Advise on epidemiological evidence causality vs. association
    • State of Science
  • Risk communication tailored to individual audiences

graphic courtesy EPA – (click to enlarge)

RHP experts continue to follow and provide guidance in addressing regulatory updates including:

Additionally, RHP scientists have joined the efforts of an international team of researchers, regulators, industry, and academia in performing human health risk assessment evaluations on a variety of PFAS compounds.

The first compound assessed was PFOA, see Dr. Frank Pagone’s publication reporting on a safe dose range. Follow RHP’s Drs. Frank Pagone and Ashish Jachak and this acclaimed team, the Alliance for Risk Assessment (ARA), as they tackle the compound PFOS.